Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Submitted by
admin
on March 30, 2016 - 11:00am
Source:
Fierce Biotech
News Tags:
Newron Pharma
FDA
Parkinson's Disease
Xadago
Headline:
Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Do Not Allow Advertisers to Use My Personal information
